Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)
Winter Park, Florida--(Newsfile Corp. - May 5, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company based in Winter Park, Florida, dedicated to advancing regenerative therapies for chronic diseases, today announced that its pivotal clinical study on kidney disease has received Institutional Review Board (IRB) approval and has been successfully submitted to ClinicalTrials.gov.
Soins de santé et hôpitaux, Santé
2026-05-05 10:08 AM EDT | Adia Nutrition Inc.
Illumisoft Lighting Corp. Provides Corporate Update Following Commencement of Trading
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) (the "Company" or "Illumisoft"), a Canadian public company commercializing UV-based air disinfection technologies and a leading portfolio of energy efficient commercial LED lighting products, today provided the following corporate update. TSX-V Listing and Public Company Platform On April 23, 2026, Illumisoft Lighting Corp. commenced trading on the TSX Venture Exchange
Technologies, Biotechnologies, Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques
2026-05-05 9:16 AM EDT | Illumisoft Lighting Corporation
Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Pittsburgh
New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - May 5, 2026) - Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced the addition of Weinstein Imaging Associates in Pittsburgh, Pennsylvania as a new clinical site in its large multi-center observational collection protocol study to advanc
Technologies, Biotechnologies, Soins de santé et hôpitaux, Santé
2026-05-05 9:00 AM EDT | Breathe BioMedical Inc.
Bachem Announces Changes to the Corporate Executive Committee
Bubendorf, Switzerland--(Newsfile Corp. - May 5, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) today announced that Torsten Wöhr, Chief Commercial Officer, has decided to pursue a new opportunity outside the company. Until a successor will be appointed, Anne-Kathrin Stoller will assume the role of Chief Commercial Officer in addition to her responsibilities as Chief Executive Officer (CEO), effective May 25, 2026. “Torsten Wöhr
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-05-05 1:08 AM EDT | Bachem Holding AG
Scryb Inc. Changes Name to NorthPalm Capital Corp. and Announces New Trading Symbols
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - NorthPalm Capital Corp. (CSE: NP) ("NorthPalm Capital" or the "Company") (formerly, Scryb Inc.), is pleased to announce that further to its news release dated April 15, 2026, the Company's common shares will commence trading on the Canadian Securities Exchange under the new name, "NorthPalm Capital Corp." effective at the market open on May 7, 2026 (the "Name Change") and the trading symbol for the Company will cha
Biotechnologies, Soins de santé et hôpitaux, Santé
2026-05-04 9:41 PM EDT | NorthPalm Capital Corp.
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of various cancer, bacteria and viruses has released the Company's audited consolidated financial statements for the twelve-month period ended December 31
Technologies, Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique
2026-05-04 5:22 PM EDT | Theralase Technologies Inc.
Richards Group Inc. Announces 2026 First Quarter Results
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced today results for the quarter ended March 31, 2026. "The first quarter of 2026 saw a few important milestones in our long-term strategic plan. We launched a series of new OEM products under the DermapenWorld brand, grew significantly across our healthcare distribution verticals, and continued packaging modernization with ecommerce fulfillment site launches and the go-live of
Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques, Pharmaceutique
2026-05-04 7:00 AM EDT | Richards Group Inc.
Richards Group Inc. Announces Election of Directors
Mississauga, Ontario--(Newsfile Corp. - May 1, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced that the six nominees listed in the management information circular for the 2026 Annual Meeting of Shareholders were elected as Directors of the Company at the annual general meeting held in Mississauga, Ontario on May 1, 2026. Detailed results of the vote for the election of directors held at the meeting are set out below:
Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques, Pharmaceutique
2026-05-01 5:34 PM EDT | Richards Group Inc.
Richards Group Inc. Announces Acquisition of the CPG Assets of PharmaSystems Inc.
Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announces today an acquisition to add to its healthcare line up. Effective May 1, 2026, the Company, through its subsidiary, Healthmark Services Ltd., is acquiring the assets of PharmaSystems Inc.'s consumer packaged goods division ("PSI CPG"), a leading provider of essential over-the-counter health and wellness products to major pharmacies and retailers across Canada. The purchase pr
Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques, Pharmaceutique
2026-04-30 6:00 PM EDT | Richards Group Inc.
LevelJump Announces Delay in Filing Annual Financial Statements
Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), a leading provider of teleradiology and diagnostic imaging services, wishes to advise its shareholders that, despite the best efforts of the Company, there will be a delay in the filing of its annual financial statements and management discussion and analysis for the period ending December 31, 2025 (the "Required Filings"). Based on the current status of the audi
Soins de santé et hôpitaux, Santé
2026-04-30 4:05 PM EDT | LevelJump Healthcare Corp.
FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection solutions to reduce the spread of harmful pathogens, announces that it has entered into an agreement dated April 28, 2026, with Innovotech Labs Corporation ("Innovotech") (TSXV: IOT) (OTCQB: IOTCF) to support regulatory planning for its coated catheter program. U
Technologies, Soins de santé et hôpitaux, Santé
2026-04-29 6:00 PM EDT | FendX Technologies Inc.
Bachem Annual General Meeting 2026
Bubendorf, Switzerland--(Newsfile Corp. - April 29, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today that its Annual General Meeting 2026 has approved all proposals of the Board of Directors. A total of 78,3% of the 74‘977‘940 eligible shares were present. The Annual General Meetin
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-04-29 12:09 PM EDT | Bachem Holding AG
HEALWELL AI Announces Conference Call for First Quarter 2026 Financial Results on May 8, 2026
Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce the Company will release its Fiscal First Quarter 2026 financial results for the p
Technologies, Soins de santé et hôpitaux
2026-04-29 3:15 AM EDT | HEALWELL AI
NewOrg Launches AI Roadmap to Modernize Nonprofits and Human Services Operations
Washington, D.C.--(Newsfile Corp. - April 28, 2026) - NewOrg Management System, Inc. announced the launch of its AI Roadmap, outlining how artificial intelligence will be integrated into its platform to support nonprofits, human services organizations, and government agencies. The roadmap focuses on practical, secure applications of AI embedded directly into existing workflows, helping organizations improve efficiency, reporting, and service delivery while maintaining full control over
Logiciels, Soins de santé et hôpitaux, Logement, Autochtones
2026-04-28 12:00 PM EDT | NewOrg Management System Inc
Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight
Winter Park, Florida--(Newsfile Corp. - April 28, 2026) - Adia Nutrition, (OTCQB: ADIA) a leader in advanced regenerative health solutions, today announced a major milestone in its clinical research pipeline.
Soins de santé et hôpitaux, Santé
2026-04-28 8:30 AM EDT | Adia Nutrition Inc.
Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
White Bear Lake, Minnesota--(Newsfile Corp. - April 28, 2026) - Envoy Medical® Inc. (NASDA
Biotechnologies, Soins de santé et hôpitaux
2026-04-28 8:30 AM EDT | Envoy Medical, Inc.
WELL Health to Announce First Quarter 2026 Financial Results on May 7, 2026
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Company will release its Fiscal First Quarter 2026 financial results for the period ended March 31, 2026, after market close on Thursd
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-04-28 7:00 AM EDT | WELL Health Technologies Corp.
CareRx Corporation to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 at 8:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - April 27, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its first quarter 2026 financial results for the period ended March 31, 2026, after market close on Wednesday, May 6, 2026. Telephone Dial-In Access Information
2026-04-27 4:30 PM EDT | CareRx Corporation
Senior Care Authority Highlights the Growing Strain on Families Caring for Loved Ones Across Generations as Mother's Day Approaches
Incline Village, Nevada--(Newsfile Corp. - April 27, 2026) - As families gather for Mother's Day, experts say the holiday is about more than celebration. It is often one of the few times each year when adult children spend extended, in-person time with their aging parents, making it a critical moment to notice changes that may otherwise go unseen. Senior Care Authority, a nationally recognized leader in eldercare consulting
Soins de santé et hôpitaux, Santé
2026-04-27 8:00 AM EDT | Senior Care Authority
Bachem Secures Financing of Strategic Growth Initiatives
Bubendorf, Switzerland--(Newsfile Corp. - April 27, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today the closing of a revolving credit facility of C
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-04-27 1:03 AM EDT | Bachem Holding AG